What is the RUPHA Drug Agency Limited (RDA)?
RUPHA Drug Agency Limited – A healthcare Group Purchasing Organization of the Rural Private Hospitals Association of Kenya
The RUPHA Drug Agency Limited (RDA) is a private limited liability company registered under the Companies Act, Cap 486 of 2015, with registration number PVT-MKUM7QV6. Currently, the Rural Private Hospitals Association of Kenya (RUPHA) owns 100% of the company’s ordinary shares, which amounts to 25,952,062 shares. RUPHA aims to sell a 70% stake, equivalent to 19,320,904 shares, at a price of Kshs. 5 per share to raise Kshs. 100,753,790.
What are the benefits of investing in RDA for RUPHA members?
By investing in RDA, RUPHA members become shareholders of Kenya’s newest healthcare Group Purchasing Organization, established by RUPHA. RUPHA boasts a membership of over 350 healthcare facilities across 43 out of 47 counties in Kenya. Members collectively purchase health products and technologies (HPTs) worth Kshs. 2 billion annually as of 2023. With the potential to reach a membership of 1,500 health facilities and a HPT expenditure of approximately Kshs. 9.8 billion per year, RDA shareholders will enjoy discounts on HPTs, market insights, training, and the opportunity to earn dividends when declared by the company..
What are the benefits of being a shareholder in RDA?
RUPHA members who purchase shares in RDA will be awarded “Full Membership” status, granting them full access to RDA’s portfolio of contracts and negotiated pricing. Additionally, full members will be eligible for dividend payouts when declared by RDA.